BBH · VanEck Biotech ETF ETF
VanEck ETF Trust
$241.12
-1.07%
At close · Sep 4
Net assets $395,554,693
Holdings25
1 month
+11.33%
Year to date
+27.40%
52-week range
$160.91–$244.35
30-session avg volume
10,184
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000034406
- Report date
- Jun 30, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings70.28%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.96%
STIV0.06%
Country allocation
US87.33%
NL6.04%
CH2.81%
DE1.94%
IE1.90%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Amgen Inc | AMGN | $60,317,604 | 15.25% |
| Gilead Sciences Inc | GILD | $50,578,703 | 12.79% |
| Vertex Pharmaceuticals Inc | VRTX | $36,005,474 | 9.10% |
| Regeneron Pharmaceuticals Inc | REGN | $24,559,994 | 6.21% |
| Revolution Medicines Inc | RVMD | $20,859,434 | 5.27% |
| Argenx SE | ARGX | $19,666,868 | 4.97% |
| Natera Inc | NTRA | $19,456,722 | 4.92% |
| IQVIA Holdings Inc | IQV | $17,034,275 | 4.31% |
| Alnylam Pharmaceuticals Inc | ALNY | $15,159,269 | 3.83% |
| Biogen Inc | BIIB | $14,345,088 | 3.63% |
| Moderna Inc | MRNA | $13,302,269 | 3.36% |
| Illumina Inc | ILMN | $12,542,657 | 3.17% |
| United Therapeutics Corp | UTHR | $11,176,869 | 2.83% |
| BeOne Medicines Ltd | ONC | $11,112,690 | 2.81% |
| Insmed Inc | INSM | $10,560,498 | 2.67% |
| Incyte Corp | INCY | $9,856,199 | 2.49% |
| Neurocrine Biosciences Inc | NBIX | $8,235,463 | 2.08% |
| BioNTech SE | BNTX | $7,680,533 | 1.94% |
| ICON PLC | 000000000 | $7,524,943 | 1.90% |
| Bio-Techne Corp | TECH | $6,097,802 | 1.54% |
| Charles River Laboratories International Inc | CRL | $5,942,578 | 1.50% |
| BioMarin Pharmaceutical Inc | BMRN | $5,294,567 | 1.34% |
| QIAGEN NV | 000000000 | $4,211,578 | 1.06% |
| Tempus AI Inc | TEM | $3,886,582 | 0.98% |
| State Street Global Advisors | 857492706 | $233,716 | 0.06% |